"ovarian-cancer"

Ovarian cancer, often termed a silent killer, remains underdiagnosed due to vague symptoms and lack of screening. With high mortality rates in advanced stages, awareness, genetic testing, and early detection are crucial to improve survival and long-term outcomes.

New research by Joseph Reiner and colleagues at Virginia Commonwealth University in the US shows promise for a urine-based test for ovarian cancer.

The test known as OvaPrint uses an approach known as cell-free DNA methylation, a promising new way to detect early-stage cancers of various types.

September is observed as ovarian cancer awareness month. It is the third most common cancer in women worldwide and nearly 20,000 women are newly diagnosed every year worldwide.

Obesity, considered a non-infectious pandemic, is known to increase the risk o ovarian cancer and decrease the likelihood of surviving the disease.

A team of researcher from Nagoya University in Japan demonstrated a new detection method for identification of ovarian cancer.

It was also associated with an increased risk of dying from cancer, most notably ovarian and breast cancers.

The research has been published in the 'Cell Reports Journal'. Ovarian cancer is the leading cause of gynecologic cancer deaths in the U.S.

Others have found that DOT1L is overexpressed in several cancer types, and recent clinical work has shown synergistic ant proliferative activity for a DOT1L inhibitor against MLL-rearranged leukaemia.

Standard surgery, removing both the tubes and ovaries, induces menopause in women who have not yet reached this stage of life.